logo-loader

Avalon GloboCare Corp

Receive alerts
Market:
NASDAQ
Market Cap:
$175.79 m
Price
2.32 USD
Change
11.00%
52 weeks high
13.50
52 weeks low
1.41

In brief

Avalon GloboCare Corp. (NASDAQ: AVCO) is a leading CellTech bio-developer dedicated to advancing and empowering innovative, transformative exosome technologies and cellular therapeutics. Avalon also provides strategic advisory and outsourcing services to facilitate and enhance its clients' growth, development, as well as competitiveness in both the domestic and global healthcare markets. Through its subsidiaries, namely GenExosome Technologies Inc. and Avactis Biosciences Inc., Avalon is establishing a leading role in the fields of exosome-based diagnostics (''liquid biopsy''), cellular immunotherapy (including CAR-T/CAR-NK), and regenerative medicine.

Deep dive We explore the investor case for growth companies

Snapshot

The firm seeks to grow organically through old-fashion marketing efforts as well as via collaborations and partnerships, with a strong emphasis on China